Arfinn Med March Updates
We are very happy to announce the release of several new functions within the Arfinn Med Platform. Those include:
* Text message updates from patients regarding their treatments
* Templating for exam notes
* Updated analytics and dosing reports
* Google calendar and Calendly integrations to schedule appointments.
Please view the video below for more information and let our integration team show you how to seamlessly incorporate Arfinn Med into your practice!
Stories you may be interested in
World Cancer Day – Shine a Light on the World
In 2018, it was estimated that 1,735,350 new cancer cases would be diagnosed in the United States and 609,640 individuals would pass from the disease [Cancer.gov]. We cannot sit by and ignore this life altering disease, which is why World Cancer Day, recognized on Feb. 4, is such an important awareness campaign to the Arfinn…
Read More 
You Can Get A Master’s In Medical Cannabis In Maryland
Summer Kriegshauser is one of 150 students in the inaugural class of the University of Maryland, Baltimore’s Master of Science in Medical Cannabis Science and Therapeutics, the first graduate program of its type in the country. This will be Kriegshauser’s second master’s degree and she hopes it will offer her a chance to change careers. “I…
Read More 
Medical Cannabis and Breast Cancer
October is breast cancer awareness month and we at Arfinn Med would like to reiterate the importance of early screening and regular tests. According to the American Cancer Society: “Breast cancer is the most common cancer in American women, except for skin cancers. Currently, the average risk of a woman in the United States developing breast…
Read More 
Cannabis improves symptoms of Crohn’s disease despite having no effect on gut inflammation
In the first study of its kind, cannabis oil has been shown to significantly improve the symptoms of Crohn’s disease and the quality of life of sufferers but, contrary to previous medical thinking, has no effect on gut inflammation. In a randomised, placebo-controlled study, researchers from Israel have shown that cannabis can produce clinical remission…
Read More 
Colorado’s first licensed cannabis R&D firm to study marijuana’s effect on Alzheimer’s disease
A Denver-based company hopes to be the state’s first to study the effects of marijuana on Alzheimer’s disease, thanks to a newly available research and development license in the city. MedPharm Holdings plans to apply for a Denver marijuana R&D license to test delta-9 tetrahydrocannabinol (THC), cannabidiol (CBD) and other cannabinoids’ effects on Alzheimer’s and…
Read More 
After A Decade Of Testing, Israeli Medical Cannabis Comes To The US
Cannabis is still federally illegal, so while more than 30 US states allow doctors to recommend it, there is very little medical testing of the substance in America. In Israel however, medical cannabis has been legal for more than ten years and studies on the plant’s ability to alleviate the side-effects of cancer and ease…
Read More